Guang-lei L. Qiao

1111, Xianxia Road
Shanghai, 200336, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Pharmacological Inhibition or Silencing of TREM1 Restrains HCC Cell Metastasis by Inactivating TLR/PI3K/AKT Signaling.

Pharmacological Inhibition or Silencing of TREM1 Restrains HCC Cell Metastasis by Inactivating TLR/PI3K/AKT Signaling.

Journal: Cell biochemistry and biophysics
Published: May 11, 2024

WTAP-induced N6-methyladenosine of PD-L1 blocked T-cell-mediated antitumor activity under hypoxia in colorectal cancer.

WTAP-induced N6-methyladenosine of PD-L1 blocked T-cell-mediated antitumor activity under hypoxia in colorectal cancer.

Journal: Cancer science
Published: January 17, 2024

Low CPEB1 levels may predict the benefit of 5-fluorouracil treatment in patients with colon or stomach adenocarcinoma.

Low CPEB1 levels may predict the benefit of 5-fluorouracil treatment in patients with colon or stomach adenocarcinoma.

Journal: Journal of gastrointestinal oncology
Published: June 02, 2022

UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pathway activation.

UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pathway activation.

Journal: Journal of gastrointestinal oncology
Published: May 13, 2022

Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis.

Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis.

Journal: Annals of translational medicine
Published: December 22, 2021

Modification of STIM2 by m6A RNA methylation inhibits metastasis of cholangiocarcinoma.

Modification of STIM2 by m6A RNA methylation inhibits metastasis of cholangiocarcinoma.

Journal: Annals of translational medicine
Published: November 10, 2021

Circular RNA circ_0008934 promotes hepatocellular carcinoma growth and metastasis through modulating miR-1305/TMTC3 axis.

Circular RNA circ_0008934 promotes hepatocellular carcinoma growth and metastasis through modulating miR-1305/TMTC3 axis.

Journal: Human cell
Published: September 30, 2021

Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.

Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.

Journal: Journal of experimental & clinical cancer research : CR
Published: January 21, 2020

Circular RNAs in gastric cancer: Biomarkers for early diagnosis.

Circular RNAs in gastric cancer: Biomarkers for early diagnosis.

Journal: Oncology letters
Published: November 27, 2019

Hsa_circ_0003998 may be used as a new biomarker for the diagnosis and prognosis of hepatocellular carcinoma.

Hsa_circ_0003998 may be used as a new biomarker for the diagnosis and prognosis of hepatocellular carcinoma.

Journal: OncoTargets and therapy
Published: March 28, 2019

Prognostic value of CD44v6 expression in breast cancer: a meta-analysis.

Prognostic value of CD44v6 expression in breast cancer: a meta-analysis.

Journal: OncoTargets and therapy
Published: September 21, 2018

CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma.

CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma.

Journal: Oncotarget
Published: December 06, 2016
Showing 1-12 of 15

Last Updated: 09/26/2026